GS vs NDRA · P/E 20, $324.25B cap vs P/E 0.0, $2.6M cap
Goldman Sachs Group Inc (GS) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
GS does not have a complete income-statement cache yet.
NDRA does not have a complete income-statement cache yet.
GS currently screens at market cap $324.25B and trailing P/E 20.1. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the GS and NDRA stock pages for the full models.
Not investment advice.